What's your opinion?
Despite an increasing number of states approving measures to legalize marijuana, the Federal Government has not budged from its stance on the flower. Their party line, of course, is that weed is dangerous and should remain illegal. Yet, in March 2017, the Federal Government’s Drug Enforcement Agency approved a synthetic drug which many call a “fake weed,” created by a company that staunchly opposed marijuana legalization in Arizona last year. This is our collective surprised face.
The pharmaceutical company Insys Therapeutics gave $500,000 in 2016 to a group called Arizonans for Responsible Drug Policy, which led the fight against marijuana legalization in the sunset state. According to the Washington Post, Insys was the sole pharmaceutical company to donate funds toward the opposition of marijuana legalization. We may now know their motive: they wanted to make their own weed, and patent it for commercial sale! “…commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care and therapeutic products.” The drug Insys created—and which the DEA recently approved—is called Syndros. It bears similar effects to THC, the psychoactive part of the cannabis plant that gets you stoned and affects your appetite and stomach behavior. The DEA approved the drug to treat afflictions that many doctors already use pot to alleviate: nausea, weight loss and vomiting—especially when related to AIDS and cancer treatment. The DEA placed Syndros in what’s known as “Schedule II” of the Controlled Substances Act, implying it has a high potential for abuse, whereas marijuana is placed in “Schedule I,” effectively labelling it as more dangerous than Syndros.
Continued in comments ✔️
#fakeweed #dea #mmj